US Patent Issued to KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY on March 24 for "Pharmaceutical composition for treating cancer, containing mTOR-signaling inhibitor as active ingredient" (South Korean Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,638, issued on March 24, was assigned to KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (Daejeon, South Korea).

"Pharmaceutical composition for treating cancer, containing mTOR-signaling inhibitor as active ingredient" was invented by Seyun Kim (Seoul, South Korea), Boah Lee (Seoul, South Korea) and Seung Ju Park (Daejeon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition for preventing or treating cancer, containing a mTOR-signaling inhibitor as an active ingredient. The composition of the present invention exhibits the efficacy of inhibiting the growth of cancer cells and ...